[CLDX] YoY Quarter Result on 30-Sep-2009 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
06-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- 17.59%
YoY- 6.30%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Revenue 3,113 2,363 2,408 4,030 2,358 1,192 339 44.66%
PBT -15,027 -11,334 -8,755 -7,174 -7,656 -5,373 -5,521 18.14%
Tax -105 -288 -248 36 -922 -120 -1,249 -33.78%
NP -15,027 -11,772 -9,087 -7,174 -7,656 -5,253 -5,521 18.14%
Tax Rate - - - - - - - -
Total Cost 18,140 14,135 11,495 11,204 10,014 6,445 5,860 20.70%
Ratio Analysis
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
NP Margin -482.72 -498.18 -377.37 -178.01 -324.67 -440.90 -1,628.49 -18.32%
Per Share
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
EPS -3.79 -4.00 -4.27 -6.78 -7.31 -113.80 -13.40 -18.96%
EPS Diluted -3.79 -4.00 -4.27 -6.78 -7.31 -113.80 -13.40 -18.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.